| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | BRD-K17060750 | CTRPv2 | pan-cancer | AAC | 0.2 | 7e-08 |
| mRNA | JW-7-52-1 | GDSC1000 | pan-cancer | AAC | -0.18 | 0.0005 |
| mRNA | dacarbazine | CTRPv2 | pan-cancer | AAC | 0.11 | 0.0008 |
| mRNA | ML312 | CTRPv2 | pan-cancer | AAC | 0.26 | 0.0009 |
| mRNA | pifithrin-mu | CTRPv2 | pan-cancer | AAC | 0.11 | 0.001 |
| mRNA | BRD-K13185470 | CTRPv2 | pan-cancer | AAC | 0.24 | 0.001 |
| mRNA | paclitaxel | GDSC1000 | pan-cancer | AAC | -0.16 | 0.002 |
| mRNA | ML239 | CTRPv2 | pan-cancer | AAC | 0.11 | 0.002 |
| mRNA | S-Trityl-L-cysteine | GDSC1000 | pan-cancer | AAC | -0.15 | 0.003 |
| mRNA | GW843682X | GDSC1000 | pan-cancer | AAC | -0.15 | 0.003 |